Efficient differential latent network analysis: applications to colon cancer
1Department of Artificial Intelligence, Ajou University, 206 World cup-ro, Suwon, 16499, Gyeonggi, Republic of Korea.
BMC Medical Genomics
|July 27, 2026
Summary
We developed Efficient Differential Latent Network Analysis (EDLNA) to uncover complex gene interactions in colon cancer. This method efficiently identifies stage-specific gene networks, aiding in the discovery of new biomarkers and targeted therapies.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Research
Background:
- Colon cancer (CC) exhibits significant molecular heterogeneity, hindering understanding of its initiation and progression.
- Identifying CC-associated genes and their interactions is vital for improved diagnostics and therapeutics.
- Current gene analysis methods face challenges in capturing complex gene interactions holistically.
Purpose of the Study:
- To introduce a novel, scalable method for detecting alterations in gene interactions.
- To analyze latent co-expression patterns for a deeper understanding of colon cancer biology.
- To identify stage-specific gene interactions linking molecular mechanisms to clinical phenotypes.
Main Methods:
- Developed Efficient Differential Latent Network Analysis (EDLNA), a novel method using non-negative matrix factorization.
- Constructed separate latent gene networks for normal and colon cancer samples.
- Identified differential interactions, followed by protein-protein interaction and transcription factor analyses.
Main Results:
- EDLNA demonstrated comparable accuracy and significantly faster performance than conventional methods in simulation studies.
- Applied to colon cancer data, EDLNA outperformed differential gene expression analysis.
- Identified biologically relevant gene clusters and stage-specific traits in colon cancer.
Conclusions:
- EDLNA offers an efficient and scalable framework for identifying stage-specific gene interactions.
- The method bridges molecular mechanisms with clinical phenotypes in colon cancer.
- EDLNA holds potential for discovering novel biomarkers and advancing targeted colon cancer therapies.
Related Concept Videos
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
